0001193125-11-106268.txt : 20110422 0001193125-11-106268.hdr.sgml : 20110422 20110422154645 ACCESSION NUMBER: 0001193125-11-106268 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20110422 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20110422 DATE AS OF CHANGE: 20110422 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TENET HEALTHCARE CORP CENTRAL INDEX KEY: 0000070318 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062] IRS NUMBER: 952557091 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-07293 FILM NUMBER: 11775780 BUSINESS ADDRESS: STREET 1: 1445 ROSS AVENUE STREET 2: SUITE 1400 CITY: DALLAS STATE: TX ZIP: 75202 BUSINESS PHONE: 469-893-2701 MAIL ADDRESS: STREET 1: 1445 ROSS AVENUE STREET 2: SUITE 1400 CITY: DALLAS STATE: TX ZIP: 75202 FORMER COMPANY: FORMER CONFORMED NAME: NATIONAL MEDICAL ENTERPRISES INC /NV/ DATE OF NAME CHANGE: 19920703 8-K 1 d8k.htm FORM 8-K Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 22, 2011

 

 

TENET HEALTHCARE CORPORATION

(Exact name of registrant as specified in its charter)

 

 

 

Nevada   1-7293   95-2557091

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

1445 Ross Avenue, Suite 1400, Dallas, Texas   75202
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code: (469) 893-2200

Not Applicable

Former name or former address, if changed since last report.)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

x Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 8.01 Other Events

On April 22, 2011, Tenet Healthcare Corporation issued a press release, which is attached hereto as Exhibit 99.1.

 

Item 9.01 Financial Statements and Exhibits

 

  (d) The following exhibit is filed as a part of this Report.

 

Exhibit
No.

  

Description

99.1    Press Release issued on April 22, 2011.


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  TENET HEALTHCARE CORPORATION,
Date: April 22, 2011      
  By:  

/s/ Gary Ruff

    Name:   Gary Ruff
    Title:   Senior Vice President, General Counsel and Secretary


EXHIBIT INDEX

 

Exhibit
No.

  

Description

99.1    Press Release issued on April 22, 2011.
EX-99.1 2 dex991.htm PRESS RELEASE Press Release

Exhibit 99.1

LOGO

FOR IMMEDIATE RELEASE

TENET HEALTHCARE BOARD OF DIRECTORS UNANIMOUSLY REJECTS REVISED

UNSOLICITED PROPOSAL FROM COMMUNITY HEALTH SYSTEMS

DALLAS – April 22, 2011 – Tenet Healthcare Corporation (NYSE: THC) today announced that its Board of Directors, after consulting with its independent financial and legal advisors, has unanimously determined that the revised proposal from Community Health Systems, Inc. (NYSE: CYH) to acquire all of the outstanding shares of Tenet for $6.00 per share in cash grossly undervalues the Company and is not in the best interests of Tenet or its shareholders. Tenet noted that Community Health is proposing to acquire the Company for the same price it proposed on November 12, 2010; a price that the Tenet Board unanimously rejected. The Tenet Board continues to believe that the Community Health proposal grossly undervalues Tenet and fails to reflect Tenet’s prospects for continued growth and shareholder value creation.

Trevor Fetter, President and CEO of Tenet, said: “Community Health’s proposal continues to undervalue Tenet. Since Community Health’s original $6.00 per share proposal was made, Tenet has demonstrated improving business trends, including the best fourth quarter results in seven years. In addition, industry fundamentals are improving, and Tenet’s Outlook for 2011 and longer-term financial performance reflects strong growth.”

Edward A. Kangas, non-Executive Chairman of Tenet’s Board of Directors, and former Global Chairman and Chief Executive Officer of Deloitte, added: “Tenet has a highly qualified Board that is entirely independent with the sole exception of our CEO. The Board takes its responsibility to shareholders very seriously. Our response to Community Health’s two proposals has been thoroughly and thoughtfully considered.”

Tenet today sent the following letter to Wayne T. Smith, Chairman, President and CEO of Community Health:

April 22, 2011

Wayne T. Smith

Chairman of the Board, President and CEO

Community Health Systems, Inc.

4000 Meridian Boulevard

Franklin, TN 37067

Dear Wayne:

We are in receipt of Community Health’s proposal, dated April 18, 2011, to acquire all of the outstanding shares of Tenet for $6.00 per share in cash, which is the same price that Community Health previously proposed on November 12, 2010. After consulting with its independent financial and legal advisors, Tenet’s Board has unanimously determined that the revised proposal from Community Health grossly undervalues the Company and is not in the best interests of Tenet or its shareholders.

It has been more than five months since Community Health made its original proposal of $6.00 per share. Since that time, it is widely acknowledged by industry experts and shareholders that the Community Health proposal substantially undervalues Tenet. In addition, during this period, investors have recognized the improved prospects of the hospital industry, as evidenced by increases in stock prices and valuation multiples.


As we reviewed the revised $6.00 per share proposal, we could not ignore the concerns regarding disclosure and regulatory compliance that we raised in the lawsuit Tenet filed against Community Health on April 11. Since filing that suit, a decision our Board did not take lightly, we have grown even more concerned. Although Community Health characterized our claims as “baseless” in its press release of April 11, Community Health subsequently disclosed that the Office of the Inspector General of the U.S. Department of Health and Human Services issued a subpoena in March 2011, and that this subpoena was similar in scope to one previously issued by the Attorney General of the State of Texas in November 2010.

Our Board must consider questions around the sustainability of Community Health’s business practices and the manner in which Community Health deals with acquired hospitals, as they squarely impact its ability to complete any transaction. As part of our Board’s consideration, we received presentations from our advisors about the feasibility of completing a transaction in this environment. Based on that analysis, we have serious concerns about Community Health’s ability to consummate the current proposal, let alone a proposal at a value our Board would consider as a basis for entering into discussions.

Tenet’s Board places the utmost importance on its fiduciary duties to its shareholders. We have never been opposed to a sale, but the Company is not for sale at a price that fails to remotely reflect the value inherent in its business.

Very truly yours,

 

/s/ Trevor Fetter    /s/ Edward A. Kangas
Trevor Fetter    Edward A. Kangas
President and CEO    Chairman of the Board

Cc:

The Board of Directors of Community Health

Rachel A. Seifert, Executive Vice President, Secretary and General Counsel

As previously announced, Tenet plans to announce results for its first quarter ended March 31, 2011 before the market opens on Tuesday, May 3, 2011 and the Company will host a conference call on May 3, 2011 at 10:00 a.m. Eastern Time for management to discuss the results via a live audio webcast accessible through the Company’s Web site at www.tenethealth.com/investors.

Barclays Capital is acting as financial advisor to Tenet and Gibson, Dunn & Crutcher LLP and Debevoise & Plimpton LLP are acting as Tenet’s legal counsel.

About Tenet Healthcare Corporation

Tenet Healthcare Corporation is a health care services company whose subsidiaries and affiliates own and operate acute care hospitals, ambulatory surgery centers and diagnostic imaging centers. Tenet’s hospitals and related healthcare facilities are committed to providing high quality care to patients in the communities they serve. For more information, please visit www.tenethealth.com.

ADDITIONAL INFORMATION

Tenet Healthcare Corporation (“Tenet”) will file with the Securities and Exchange Commission (“SEC”) a proxy statement, accompanied by a WHITE proxy card, in connection with its 2011 annual meeting of shareholders. Any definitive proxy statement will be mailed to shareholders of Tenet. INVESTORS AND SHAREHOLDERS OF TENET ARE URGED TO READ THESE AND OTHER DOCUMENTS FILED WITH THE SEC CAREFULLY IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. Investors and shareholders will be able to obtain free copies of these documents (when available) and other documents filed with the SEC by Tenet through the website maintained by the SEC at http://www.sec.gov.

 

- 2 -


CERTAIN INFORMATION REGARDING PARTICIPANTS

Tenet and certain of its respective directors and executive officers are deemed to be participants under the rules of the SEC. Information regarding these participants is contained in a filing under Rule 14a-12 filed by Tenet with the SEC on January 7, 2011. This filing and other documents can be obtained free of charge from the source indicated above. Additional information regarding the interests of these participants in any proxy solicitation and a description of their direct and indirect interests, by security holdings or otherwise, will also be included in any proxy statement and other relevant materials to be filed with the SEC if and when they become available.

Tenet Healthcare Corporation

 

Media:    Investors:
Rick Black (469) 893-2647    Thomas Rice (469) 893-2522
Rick.Black@tenethealth.com    Thomas.Rice@tenethealth.com

Joele Frank / Andrew Siegel

Joele Frank, Wilkinson Brimmer Katcher

(212) 355-4449

# # #

 

- 3 -

GRAPHIC 3 g178241ex99_1pg01.jpg GRAPHIC begin 644 g178241ex99_1pg01.jpg M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$" M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,# M`P,#`P,#`P,#_\``$0@`70"H`P$1``(1`0,1`?_$`,X```$$`@,!`0`````` M```````'"`D*`08"`P4+!`$``00#`0````````````````0%!@$@1``$"!`,$!@<&`P0(!P`` M``$"`P`1!`4A$@8Q05$'87&1(A,4\(&AL<'1,N%"[RK-;*5UU(VJ`,A/I,A[9PF?JZ:C1XM6L M9=DNGU1`CF_W:_3[H;EVPP[C3/\`GYRV%4B4FQKL-C.J/!(82D,C(WF42L"C M930!`Y8D1`![2\3ZU\E]452O%K7&Z=!XS)[,/?$LL_*\HZ@B"S6N5BNI**F#M$J9A[`$.)HUR+I M4$&JN2G$;PE`0>U2E^Z&=6N'G@0BG,N/>^R-0AO=)=5Z[G*>A;'<5SZ"G,9, ME;Q-N*M:1B#^H)7,;+"!]/O```1X7'E-H2G&2KK'D.C;^8B0X'Z!MCHWJBZJ M0"U2YT<>/JA6Z_[C/K5($*\G>EJVLD>4>90T?@K=%"?LP_6Y70)S!$Q`NN@] MV;01[0T[.&ROY;*DA\D8ZK*:P%#40#S(G:':(<-)Y+4 ME:G-:[VPO@#(`G?Z8ER)2,GU)V4AVUE MH-HA;?"K3.F)6S%FDJL?]8W*0#&!99+7=;Z MZBDH&5.URCBA(.`XGA*.534,4C)<>,I10-ZC7N@=V&Y>0G:!L\2DMI^#UO%, M$[4U59N=P=P9"`(`Z?V$!<16-VSQ,3&*UB06?(\Y0,^Y@'CTOI?E!06Q+=1? MD&HN$@HH,O"2#L24D&9$C,DCJ$5M=]8N!1:IR`C9AM/IV1$1LPZ=6][JBY1F M#X7IMAOR@R1/4K<'E68ED*+7W+U85UE+;D:<\PD;#8.[`QBQT?YA)''03)D* M.I;`O>KM'Z0H1Y@!I8P2RR0E4^,I&8&P[-HF1#316F[WE7C9E%D[CLBY7L\] MIQLZQBPBY_=SD&\[G;PD"3A_68-[(8KQ`T7CS[?^=.H;DXIJTAII@_25#,M/3.>68W8$;.J)C1Z/H$)G5YBY/<9 M#CO$_=%@K"W3VV-[=F39CA3:=@/'WA!3,C(0^,JLM/`=/3E44LDI'/[`NKV` M(G.Y,81#41UXKRZ:IU)>B#ELS+/NV1*6J*C9^AI'9#O&S-JS2!!H@BU M1+H!4FR2;=,H!\`*1$J92@`?<'#!(GZBI1XDXPH"$I$D`)'`81W\H?>;_O&_ MCX)`>AC,H_,Z8M'R1D'K9!V@<#%.@Z01<)'(<-#$,FLFWAWMVH+]:CFHJRH2K\4_8/'E+<.W92@8X1ZH\-E&10&!X`DX;`)0HIUUB5E#^4M`"1`QGO)WR]7K,2^8_OU5RA2JOD*CRH3E1N M,0TG:_*^!D8P[R-?$YT%58V7:1\K'+E[2J(.4$7"*A1(H0I@$`ACZ7V'0WEF M,TCT=._"'(`$$QN?&\:P<$$'!!!P00<$$'!!!P00<$$'!!'S]NKAL,ZY74RW M33U_?;5K!%8%HCZ1K6WG&3C+F)48VL5--06RUMEF!+L#5:\7=1OXM\Z,!E$4 M%$FA#=TC^+TWH+4&@=%VOPD5+2KTH]YX"9ZA.1EP$5U>:*_W-7Y:2&^F?R_T MPW?9'[8;?+DO;0O0?;G&C\PY#L$1D*CV*UVEA%KIF)0:JUJLW,N(R5 MLAS\BL@X(5-BT*JHGSK'?5O.2SLVM2[$YXMW(D2!W>@DSGQF)>O&$MHT6 M^JH%1<`GP1NGC/JEZ>^[AF/AO.HK43(KQZHYC[D[HY!_\`U4L/YL19 MC_U$#C9'*_72Q/\`3W0.DH'^]!^X+6-JY>J'G;,>J7LBZ@5CO53VHY=5R7.X MV@XBQ7!F>F76K!%1,Z_=1L6X!:V0$*B[%T\9*D`J)CF#EU$`#ABOFE+[IQ*% M7EDLAPR3,@S["85TERI*Y2DTRLV4;=T;[NKZA.S+9''-9#='N!H.)%Y%N9U$ M5^:D%']QFVY!Y17AZ9!(2EI?M^?\(*D:=T)_P@;4!#A+9M/WO4#I9M5*ZZH; MY`)[291U>K:5A.9Y:4CIB.^J>Y/Z/MKL2-=#"W7Y>+B^2R3'3W14Z.PYB^SQM*N%TN$;9J2U:VR6C"S,97HN/M,+%2]CEGT: M8%4T(]NY4$H_#CJ]HW4M+7IMZZ)TUBTS[H!P&&)!D,>F.1N="XWXH=2$!6\^ MZ&^5;W&71[MEJ:U5MNTCH9=XZ*S;SEKQ[DRL5(RYU"II]]:)FI-(AFBH8X:* MK*)I`'XA,``(\.U1RQUQ3-BH!L1M!$OMAV2M"D!Q)!2K9'GW6_P!*QM69JZY#M-?HM,KC0[^?MMNF MHNNUN&9$Y0,ZDIJ6=M&#-'4P``G.`B80``U$`'%.AZKJ/*T[;BGR9``3GU2W M1E:DMIS.$!/3$--[]QST@*'8%ZZONI0M3AJX\,XDJ#CK)-RKY%`.)#F3GX>J MK1;M%,P#JH@JJ00[2B(<3NDY:ZOJT9TTV3#8HR/8)^V4-#M^MC)(+DR.'H(? M9M/ZC>R??`T>K;7MPU"RE)Q:`.9>IL'KB&O40W^UQ(TBQMHBT-VI/Y2WA11* M/8)]>([==.WJR+R7.G6UCM,B.T3$*Z*X4=>!Y=8).XX&/!WJ]339OT]38[)N MOR:^QR.5`L8TGPU*N5M"4^4_*AG04&I0DSX(S,)IN(`MR"<##RZ\HZ;6'3MW MU*MU%G:+JF3WL0-Y&$^J,7"XTEL(%6K+FAB7_,M]'7[=S),OE;KA&VB43T$'XPF-]M@3F\02@_YEOHZ".GU.RW_TUF+_`%)XS_VJ MUYD\3R#F6?$?.$W[GM(0I969),MGNQB0;93U%=I?4*@[[8]J.1G>1(C&'SB,Z@TU?-+O-,7 MJG6TXZ"4[#@)3)D<-H'61#G0W"FN+7C4Q)1TX='PA[_#%"V.D$P+KIKH/V"8 M1`.T1$0U#741'C3\C@GL@SN[`?\`K`/W\XB/P-I\==0#F^'PX"$+$A]/ M1A!,G%6V(E^K1TK*_P!5K$N+,4V3,U@PJAC/)#G(Z$[7JA%V]U+.5ZW)5L(I MPQE9:'1;(E2?BKWI3B;4@%Y=!$>)KHG6;FC;JY7BF14A=.IO*HR`FI)"IY58 MB1W;]L-EVMZ+G2BF69)SA78#\XI*]9;H44[I381Q1EJM[D[=FMWDC*BF-UH* MQ8_@J:UB&Y*C.V?S=)[%6&8<.E@/$%2%,4P#E4UUU#B_^7/,=_65V71.TK32 M0C-/.>,I2R;HKW4FFJ>WTH?2L[80KHJ]).H]6&Z9_J-LS;:L+!A>K4*R,7M5 MJ43;3SIKG,66,6:/D9N2C/!$CRP!3I&)J97O1U#\/#OS,URO1+5/X=(R\'3_ M`!'<.&3&!Q''V1:2QSL0QO[:G;)O:MXM]E73HI:="YR05,B?83$XIK0G3-.[4(5F1DW\<#Q,4V]J6W3< MYUFM^7RC/9)>3F5\KNK!D++F9KF5_+-Z=2H<$7$W+-HM-0"I1T<=ZC'0T.W4 M;H@95!(.0H&,%\W6Z6OEO8BIID!#8"&\L@5+W#JVS/K,0"G34:EN!0M1#6:> M_=O[,3%D?<=[1&*K6&+%8-L&ZB^7C,=8A7\NSI&4JG5XZKWQS'-3N%*_$2=9 M%)]5I.3*F*;,ZX2+<5#E*MH`BH%7VGGG4UES;HKW2%FW.K`4I*M@)E,X"8X[ M)8Q**[0;+%/YEMPE:4YO6,>)W_9$3?M].I'D#8MO3J6!;M,RC7;IN)O+7%^1 MJ-+KN"1N.H[ M$;W:TI37,()0!+O-C';U8]<-FFKI5LW$4M0N:"9;?3TPB2WWC*8>K&PX!Y>S M'V=PYC")0*(67'(\WV`7[>WB%1S*UGV2W@`'VPXZZ?936TZ%S"BF? MJQB"GIA=*/='U59FUU+%=KA*#AG%DM&RF0+]=GDR[J-?M5C9*MV#>N4Z%$%; M'?9"$B=3G(+8J+4B8*N"E,4IK(UMKJT:.J/,U04]4.-R0E,@1EQS8[L93B.V M73[EXSA#BDH2J9/7NGZMGRC<^K#T8LT]*5?&4U<,DU?,V+\MNIB#K-ZKD3(U MA[&6V#9(/WM;LM=E'DCX51U%*&<-'"+E5!P5$Q>5,Y1`4NA.9=-K,N94.)J& MAF"29@\,<)@D8X8<(YZBT\JSE)0LDDX'IP^8GT18C]H'N8R!::-NIVI629DY MND8B7H63,8-9%XL[)4VM]7L<5;*[#@N)P:03R6A$'Z*!!!)-9PL)2EYAXJ[G MK9:>BK:>Y4B4HJJ@$*D,#*1QZ1CV]43#1=34OTZFZI68HEZ?/C$-'N+NIE>] MWF\;(FW:KV:1;[8=L-ID*)#5*+=N4X3(.3*\4K2[7ZQMVQB)3;B/GB+1<21; MO$6C=J*A"E67,;B?\IM)4EDM:;WV9Z8@5WR[-MSG11WMU6)A_CO`3,4HJY:+$'L$Z2Q.)_I^_P!NYJVI MWSS*$J*"E0$C*?I,<1#/V'$N+&4J,CEF9?=,]_SB9OVZDU-1-5%2K'+N[=Q$5C>M7T:J MITFF6WMQ6<\VC-ZN;WF0&KTMCHT-325T*0WKCA%1H:)FYD7YI,TX)#`H).[! M/4/CQD1=TZ1_26J'2=IN9:74LU6G-"&9K?6K:\?VFIPU36@G-9@7,(1 MFQ0AI&13>(/$W(JG.>M-6S_3);LT41=CNY/>CMM6IQ1<;M\G2IJ4\FXJ3.1S'NZW9DXJ/7FHYK^\`BF8%" M@3G_`!R92)5=)!N(S"QE^4A2)DU'0H!Q.ZBXZ;%H5;A549;9IE(3B/X2.$1^AM] MT5=DU+Z%`!4XM#>[Y=KO[MT\7SH#%=/<0YB=.2G*8IRN'$IC!53#:&E71MN61+B@);)3W1)]:$J73*.WP_G#S_`&=G]FO>;_3Y M1_ZN$>&7GQ_U%1?Y0>]4..A?Z:Y^/YQ[_O"1_P"$':E_^E),/T^F5D-_B#A# MR.QOE3_[7SCOK?\`IZ/Q?*&,>SH`?77?08.T0Q/A;0H#IS&&V7<2]H_E+I^G MB:<__P"E6[_./?W&8;-#S\=^7_ECWQ4FRO+2LIFC*D\]%5687R!,O=%43IK%<*^.,`"F)3`*P7RZY9&H<"G6UJ6HDS>*AMWFZNI$Q4\Y:O91H)*Q1XI)Z#AVQ3.)E@ M-RZ=FG$PT_:-':4:7^D/,("C,GQBHSV3D=O5#;=E7VZ/(><0KN1NNS5D62@B=,IB M\^H".H:<4#SH53OZE34TSJ70MG:#/81+WF)YHYBI:H5IJ00J8^,,V]Y%IY?L M#+KVA-YV-I^0(['P=GY=1XD?($G)7D[9(]YAOUN),M@<(5CV*&7.1,TID+';OY@B(%-8X0Z16AQ`X#IS:@(^2'M!:YIWBP[1+,S))`$CC( M8C`=?KBTF[U:WF\[;J-DS#+\=^Y7V%Y@WJXRVGXW=VF1HV1G4VJ;?8%W>M;F MM`F6T*FI(&V9&T[Q(G#?.&MO4-'5UHI&'!MEL]/GT1"[[QD!'+&PTHA^(<>Y MX+RA\1'YDQR`=@ZCJ;3\O;]_$XY"^!Y.O"86Z M%21;')[<_P`X]GWA/]D+:B'VCN6E-/T8OLPC_`'"'D7(W^IGL\+YPHUJ`:%L M'9G^4,8]G080SGOH$.TWI1A8P=G9V6V[Z%$WP*`_;V?#M^SB9_\`Z`4WY*V- MC!)=<4>M00"?]D80VZ%$W7COR@>V(2^MMLFO.QCJ%YI@U(MY%8WRU[>[;;FJJ83^27)B?>P]?IV1=AV!&;ZX4FW.P-`24+83MO$@W5<)/& MJJADC)FY0.;SKJSE=J.TW1Y5JIW:RV+65)<2)CI2>!'0/;.)[:]14+](`\I" M'$``S$I^DO01ON[WW(731VT5*87H&7&>Z+):;92G=_N:=CR& MX:I4ZMQ*JP@"K@J[M=,->5`PAIPUV7E9K"]5`IW*93#2C(J4J1`Z`#,&,5&I M[8SW4.)4X=DI[?3AMB4[9;NTQ5OEVWXSW+8AD@>5;(,&BY=Q:JQ5)6G6IH'A MK32)],NAVTY5Y@JK98I@+S@4JA0Y%"",4OEGK=/75RVU?UMJET$;CZQZYP\4 M58FJ8SM[Q%27WD7ZFP0G_K\[B`=O:(L\>\P_P!^CB^.0>2=QGP3[S$'UQX@8 M;R[D_&%?]G-_9]WM?9_MQQM\?Z/W?;V_DX;N?83^L4.39Y=7]Y,=]"9C1O%6 MW,GW&+D^H?8.OYM/S<4(8G<&O_3L_CXUF.(C,9XVC$'!!'$P:@'Y]?\`'QA0 MFDCB(R#$+'6WZ7&0NJE@K$.),>92I>*I''&6C9%D)>ZPDU.L9-@-2G*[Y6T; MPBB3A%R=>5(H)S&`O(00^/$]T!JNBTC=G+A6MNNMK:R`(RSG,&9S$#=QA@OM MI>NU&*9I24J!G,S^`/NAO?0[Z*>5^E)>MPUMR1F['N6F^:*EC^N136E5ZRPC MB#5IDO9Y)PM(*3RZY'2+Q.?*5,$^42"F("&FG#OS+UY;=;(I4V]E]GP`0?$R MXX#9E)X;Y0GT_9*BT*6I]:%9A]V?'I`BQ7R_P_>`C]W\/%5RD2I,IG;\(D\S M*45S>IC[;_:SOTNUASECFURFV/<#9U7$A;+%5H1G8L>Y"FU?Q&F[G17+F,!. MPNC_`/F9..F[\\T*)MW&VQ.!!40"2+4\EJRYV_-J3FB3L@;] M\.NHE%Z(:_ROMXM7_OO:`5*\I5J*DD25X4@2)8=^(VWH1]HG(\D),]ZM_1E^ M,3,[#_:X;0=K]LK>5-P-VL.[')%6D(Z=KL18(E"F8CKUAC5DGK.73I4>_DY& MRO8^1;IKMS24@H@10A1\/J`<5_J3G#?[W1?IE(E-+0X@Y<5J']H[CVQ(;3I. M@MTG%S54<1/TE"J=<#HJY6ZK5SV[V;'6;<=XH;X7K60X*7:7:M62=6FU;G*U MF2:.(XT$Y13;IL2P1RG!4!$14#E[->&S0&NJ#20J45C3SOC##PRG#`#',1PC MM?+(]=%(+2TIR)([T_@#"Y=$7I89#Z5.(7D$`TUX096I>*7^,\JO M,A/Y2ZP3D`0^/9QKR\U;0Z-N+M97 MMNNI=1E`;RSGCMS$#?&+]:7KLPAII24E*IF<^C@##?\`H?=$[*_2ER#N$N61 M,VX[RPVS+3Z'6XIG2J[9()>%<5&:GI1TYD#3BBJ;E%ZG+D*0$]#$%,=>P0X> M.96O+?K5FC:M[+[)IRD>Y*IJRK6*>+S%%NU==A#9`QM85T"MU)NG6#N'/A3N4R`FZ:K)+, MGJ(`19$V@"$,TWJ>]:7K_/6QW(=A3CE6G^T..W'=NAZJZ%BL;R.@&*@V7/9X M9V96)X?!.\+%-CJ9U3C')9=H]IJ]I;-S*#RHO'%,-8X9^HDF.HJ))-"F-\$B MZ\7E0<]66V4MU+56VD;4-%M223MQ44GV1":W1+C[H4PZE*,=ZA[@??"F[?/9 MW2:4NR?;I=X,PS"X%VVT1K0<=0SMW*G9D>/966G;#)`B$M:++-R*J[^9L$OX=,5W"ANWD M*4H%(4I0H:ZW.OO5>JON"\[RMN[TWQ-*:F:I6O#:$A$2W7&Z.N5.J\.W+TXS M-0,2AA%?(BTM\[5VPSHSHW1&MHM"QXP:R7A09!"'%3O/UN<-/@.D^Y<:XH-& M^:\^R^[X\LOAY<)&>.8CV0SWVT.W9I+;2DI4D;Y[?4#&[=#_`*461^E'C3/5 M$R/EFDY:?9@OU6N,8]H\#.P;:':5VLG@5V;Y.<544<.'"RH*%,GH4"]@]O"3 MF1K:@U?74U11-.MEII28@[)!*3MZ2,(Y7'4]NMM M0*=S,M9_AD1[2(0S`WNJDL\>N#?@0:H'.;X!JLN?)JKM%K7=;A7T;;"-Q#F8]6$"PR\3QD)>^+9'%01*(.""#@@@X((.""#@@@X((-/\`#P00<$$:A=FM MP?56RLZ#,1%>NCF(>I52S,&UD8=U*QB3KE%9!)VW5.GJ M!3E'00W813-O!Q\$H4<9;9;,-T^O",.S#>0\\`"6UD(<$]P"B`LSP[OVPTBY.4JR'FUY2,"`2/3MZA$D>%-Q^`M MQE=:6S`V:,99>K[M--PG(X]ND%9TB(JAJ3Q:$:\7>,%!+V]VNFF`DM&8C`3Q[#C"Y:@'Q$`X0=.Z.D' M,7734-?NU#7@&(S#9&9$">Z,"!3=@]OZ?XAX(UF(SJ'WAV:?;_!_#Q@D`3.` MC,Q!J`_`0X$J2H3201T00V;&@:RB=Q8["]6$H@5%DT7.81#0-1X<*6RW.[J2S;6G5K)E-*21/KE(>LPF MJ*RFI4E3BT@@;)X]D4E>JG[H>X9N@K-@CI[QUGQ9CV7:O8:U;BK*W\ER;9XM M9,R+YEC6!Y5U,?M'*!OQ23DQY84C?LTFI_Q<>@]%\E54N2ZZA(74ID6VQ(@# M:F"#K$68Z_.LY>.!66-J*953ZE-N* MFD4[*?HF`I6X`)G,XD;HAM+9KA<7_$OA]D?1VZ,W0\QITR:XMDZ^ MR47EG=[@FJ_HV*6S],KU!BY5(4)&56`CV2$A2@5%`` M2X\G:]YA5.LGE(2%-6MLD)1B"KI/P`GQ,6K9K,S;&0K:X8GYXKJ'^#@@@X(( M.""#@@@X((.""#@@@X((.""/*FH:(L$:\A9^+C9N'DVRS*2B)ADUDHN19N"< MB[1]'O4UFCQLL0=#)J$,4P#VAQE#C[3J7:=2T.),PI)D4GC/;V1G*%"1$Q$$ M^Y'VZVP#,-D>9+PDSR)L@S(JHH]0R#M3MKW'C(\D=05O'25(;*#6UOQF'F!F M6/,'O$6=3E$2 MZDEFI1TU_#KV2%O5'*R\JSWBTO4KRAWEMDA`/X009>K9#2JU7^C_`.2?*T\" MK#_:^9A%)[J$>Z1V_F52RAT\L>Y@:1X&!S.4C';FRM'A4QT[\%\49*D0`%@# M74&J?_9#X<.;&G.3ER2#271YH*$PDD@#_P`23[R8Y*NFJZ;N/TX6!A,8S["/ M9"$V?W)?6*I1EF-NZ8,#6)!`>[_GC#VYUL)%"]BO[(R@$,4!$.TI].WXCPYT M_*OEW4S73WE93A_Q&D]7U@3]7KA*O4E_49-T121MPV]JH0N<]R3UL;FLJRHV MSZH5ATN'(@G"[9\ZVQR4YPT**02\F9%14!'\('*8!^T.%C?*7E^E04_=@MH' M%*GZ?*H<#EDJ75C'%S46HT`J\K),L3+9[3.$6L^ZSW0V[Y%2'B*KO$K<3*D% M,6>*\%)8%C!;N@,4R:MB7@8.;09BF(@8QI#L#XFX=467DYIT!52BE?"?_6)] M@7#>:O5-PFE@+2#"?X\]MMUB-S-F)<9UD)2\I@*\CA4+V&*`#R\5U?>=]]K$J8L[`I4$?43-78A^46B\%;=L);9J1'8TP!BVC8CH,:4GAJU1*^R@6BJQ"F+XN35 M;)@[F9!0#:GWY0YL@GY0$Q MC#VC\2@'V]GV!V<,+#JRD9PL]\XRVIQENV;,8ZRPQ5[HY\PAS:F_5[1UT[`T MU'7[M`'COF2`9J5,3)PW=G9&1*[`50!$2\VIBB`"7300U`!#7[M0'C9#B)Y"5%72)?`1J5`X)VQ M&+N3ZLNV#;%N!DMLMP@MQUXS##T2O9)EJS@W;KDK-18VG6AT]CX67D'-#A98 M&*;E_'JI""G+H<`#7M#B56S1][N]&FY4BZ5%&75(_-<")D)&&)&_$<80NW&D MIJE+#JE*=(Q2!Z^O9[Q"W;-M^>W3?7`7NPXPXS+.3*IA;%V1R-0M%4R%MG`C"%4+H``4!U$NFNFHCKKKJ(%T_P\)EO MM-+#82K9/NI.`Z@,(ZM)RM@*,U2VQR[=="B.N@_A$1'[NT>;73C?.GQ`DYL1 M/9[\,)1L<5"?TP";0W*(Z"/84NG;\!$0#[]`#7C1QQN?A=X*Z`9GLCF@'.G84!`=!'7MU^T/C^ M7C"FD+^M(GV8^J-<03QCD!"E_5``_-V:_E'[QXV4D*(*ID@<3`5*5M,9T#77 M[>-H)G9&>",0<$$'!!'$P:AIQQ?;2ZT4*V&,@R,XKI^X(Q91,YJ=+3">48U. M;Q[ESJ18XQU*BF+E.%`EM3:QXAGP))(P$@9G`PULN.FX M-L/I,Z9!!7N65'=W+[P8VIY2A; MSO!W%67?OWRU:\`3.PB+Q]+TN)I;ZOF%FU78H]PP;$*N9TF8-22RXTE ME:9-&*0FW&@24+2UF;2>ZH$.`8J2.ZK&04)R&,T-+65=0I:E=U7B+D-\IF7I MOV=2B9XRSOBQ-E+*&S3&=PR@[9]';<;G[?S=+,[O-E<260]MTED3%]HQ?0W\ M@]E%I&=80M-NLL!FS_OF/AS?A`P(?AXV.RZ=>H6+\\A"6[L$TC84/Y;GAN'. M=D\RDG8!C(`QAZHN"5J9((#<$5)1O3\7XE:9SQ^Z.WQM(]%VS92:DB M14H',D0!9D*MMNOCML;MSCR**B33EQIO.?$!"E.Y"%890%99$D$]<*FFZERE M-2X]E5CW2)3(.\D@<1,REQBP)[?',#C(^SG(M-D97)TW*8&W(91Q'(260XB`24BSQ,IY-B/-L;#1"V0,70:DH="/00K[F'0LT=Y;53 M!O(\TE8RI*2)XR4"=H&&[I$Q#G8G7:EK.I)2)[]OIZ"&M99I>[>]]?K'&V+LC>@FGK\P^^P;BL(2TZEM0_+&*BI*P1M&SUP/^(+Q^3D2LMR)4"9 M[-DI8[-XV1%;8,D[JL#[)NM[DV9R7:T^I4PW@X2QAO5ON/D65;K]7P$=*+AZ M;DG#3"L0P3U2I\MC:;=$/**-U9%FD"JJ9A,D!S3+R]GK;]8:1:"=-BC+C"3- M2BX2KNKXD8&7QA"E:VZ>I=F`_GQ(V$$GXC;\X\7;C9[O2I#>;C6D;F<*7[!> M2NE-N5OMVPKB/=KG?>K'1\_7L,C<`"I(W'?*0L5P4DGD#(=5&`RV2GN[_3C.%]>;D[SF_;STR\`YBR]D MO)2,DNMM?R5_F9B69*,U2&&/T2,XZ*J'WF)%T)42)3G(##&?#L&, MX]&][O,ZEZ7^#<45?)V7:GC"$ZF&0=L6Z#(]^W2R]PHC"H1<-&6*M4"O[S<: MU!Q;V>VQ[.OQ:>=E;OGY11%`7*B1M"IZ2QV8ZKJ7JID/K70!UEM+2DK*R92\ M,SFL"0$AQ!$)G:JI4PEL+(RG%4L)8>OB3CTQ,ST#+;E")SSO;P@KGW%^8<&U M%AB^YU"D8BW`9;W:TW"5VM1I5">KL+N)R14HQ.<;6F.9)OE(A*2?+QRA.TJ8 M"8PP#F32T2E4RFJ9ZE-5SRX00BF6?0/S3&/K;Z4^<>H45Z,>IORMYCZK>$>>3>FGS(/B?G[P7?^&\ MM_?^[YN3LUXZ4OGYU/E"[ER#-(&67?.1^GC.4)7^G7ULH?S/Z/\` MU%_*]E],//OE$,T?)?*K\W_(WF&MU^6.3O/'^!_=?U^\_E<=61_5OXE?F\O]&QW` M^/[K]ZYO#Z9!\P[C_.?^+R_'LX[N#4GECXQKS;_#5L"@UEPV3)'7NC@P:+QC MD#7BX;#]DHWF;^D+YWS1\P_3MZC^G+'ZBO.O3SYT])/+EO+O6;QG\\ACWRKG M[KSK^;O#_#\'"*G\[Y*ES>:\KG/A3SR\22OIEWBW=]T3R?TS&1_T8[CPFG)Y0 M'+X?77]GKP[6W]Q^9<_3/.^>GWY3S2_MCA*@?<.ODST'^51QMR]^;Q_E(T[2%\3XO7Q&G[7O?\`.?BX:+P+ MM^KI_5R[YB7WAT&6,SAPD)0I:R>#^3++NE'M,O07UNLGE?I7]1OR%#?-HL`K M'K'Z8^:J>0>?@W'YN^2/.>?PG?\`[EXGF[O\>O"A/ZCY),O$_2O%5EG/)FRX MRF99MN[V1R:\+S(SY?,93U_+9'@-_I<^?LT>%]"O4WYLW+_.H5WR;OO!^=_N_AN?N_PO#C"48>_NZ?D?+'H!]&OISY;*>N/I+Z-?*'DOA7/G?JA\I_S M5Y1X+OO$>:?L.[Y^;LYN%E=^OYV_-^=SS[D\T\V[+/'-PE&6O*YS(-_1CCN[ M-GV=$=&5_P"[@]+\3^N/T8>C?E3#T.]5O1CT[\B\"V\L]+/FL?(/)O+>X[GR MK]W[CN^7\/)QI0?N+Q7?+^?S3[TLVV7WLN,Y?Q8RC)\I+$-]H^(C1=WG]U/\ M@XC^M?Z*/3C0/0OUP]*/E?PWA6W^[+S[]R\K\'W&OEO[MR=WK_(X=+!^]2]5 M?H7FP]+\W?C_`<AFX?>]L)ZKR.5/C!N6Z9^0V>R-3R1_7S?T*]'_`%3\)&>)\-W7^CWSWY=X7O\`N?W[P_=]Y^#EXVI?WS^LK\CY M_P#5?"[^;-LF8:=_P!]^/Q&G/\`CX9*_P#6>;:/HE[)=WA'8&A\(S#7@[\=W9"D[/D`*5Y MSH'B/$^G>L-YGRZ<_/\`M=-->$UT_5<[?ZEYO-+#Q9SE_K8_"-V/*2_PX1+H ;/V0XH--`T^&@:?FTXY0H.V,\$$'!!!P01__9 ` end